Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185037 · ClinicalTrials.gov registry record
NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 17
- Enrollment target
NCT05185037: Clinical Trial study, sponsored by Philips Clinical & Medical Affairs Global.
NCT05185037 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05185037 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.
Primary Outcome
The primary endpoint for this study is the rate of NIBP measurements that are valid based on evaluation by a panel of three independent, licensed physicians. Valid measurement will include no technical alarm (INOP).
Interventions
- DEVICE Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-05-26 |
| Est. Completion | 2023-11-16 |
Why NCT05185037 stopped before completion
NCT05185037 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes) is the first listed.
NCT05185037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05185037 about?
NCT05185037 is a clinical study titled "NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)". The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.
What is the current status of trial NCT05185037?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2022-05-26. Estimated completion is 2023-11-16.
What interventions are being tested in trial NCT05185037?
The interventions under investigation include: Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes) (DEVICE).
Who is sponsoring clinical trial NCT05185037?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI